Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,231 public trials 1,017 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

NCT02728596

Conditions
Agranulocytosis, Breast Carcinoma In Situ, Breast Diseases, +60 more
Locations
  • Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States
  • Contra Costa Regional Medical Center Martinez, California, United States
  • Augusta University Medical Center Augusta, Georgia, United States
View all 160 locations
View Trial Details
Completed

Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC

NCT03164772

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Research Facility Gilbert, Arizona, United States
  • Research Facility Tampa, Florida, United States
  • Research Facility Detroit, Michigan, United States
  • Research Facility New York, United States
View Trial Details
Completed

A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

NCT03066778

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations
  • Baptist Health Medical Group Oncology, LLC ( Site 8000) Miami, Florida, United States
  • Rush University Medical Center ( Site 1215) Chicago, Illinois, United States
  • North Shore University Health System ( Site 1216) Evanston, Illinois, United States
  • Community Hospital ( Site 1207) Munster, Indiana, United States
View all 148 locations
View Trial Details
Completed

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

NCT03241173

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +74 more
Locations
  • The University of Alabama Birmingham (UAB) Birmingham, Alabama, United States
  • Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Mount Sinai Medical Center of Florida, Inc. Miami, Florida, United States
View all 15 locations
View Trial Details
Completed

Pharmacokinetic Boosting of Osimertinib

NCT03858491

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Maastricht University Medical Centre Maastricht, Limburg, Netherlands
  • Antoni van Leeuwenhoek hospital Amsterdam, North Holland, Netherlands
View Trial Details
Completed

A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)

NCT03085914

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 16 locations
View Trial Details
Completed

An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma

NCT00738582

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • University of California, San Diego La Jolla, California, United States
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 28 locations
View Trial Details

Related conditions